Securities and Exchange Commission

Devices & Diagnostics

Minnesota company raises $29.6 million for implantable hypertension technology

CVRx, a Minneapolis-based firm that has developed proprietary implantable technology for the treatment of high blood pressure and heart failure, has raised $29.6 million for advancing clinical trials of its Barostim Neo, as well as expanding commercial activities abroad. Johnson & Johnson Development Corp. and New Enterprise Associates, Inc. were the co-lead investors. According to […]

Devices & Diagnostics

Medtech company raises funds to help eliminate MRSA nasal colonization

Med Dev Corp., a Delaware-based startup, has raised $775,000 from private investors to reduce hospital-acquired infections or surgical-site infections. Med Dev’s devices all attempt a non-antibiotic approach to eradicating nasal MRSA colonization, which is “the No. 1 predictor” for SSIs in orthopedic, cardiac and GI surgeries, according to Chairman Mike Martin. The company still seeks […]

News

Stem cell therapy firm Aldagen withdraws plans for $80M IPO

Stem cell therapy company Aldagen is pulling back on its plans for an initial public stock offering. The Durham, North Carolina-based company said in a Tuesday filing with the Securities and Exchange Commission that it is withdrawing its IPO plans “due to market conditions.” The company in 2009 filed a registration statement seeking to raise […]

Devices & Diagnostics

SpineForm raising $1M for scoliosis device

SpineForm has raised more than half of a hoped for $1 million to further development of a scoliosis-treating medical device. The company has raised $539,000 in equity from 14 investors, according to a regulatory filing with the U.S. Securities and Exchange Commission (SEC). The latest SEC document is an amendment to a filing from last […]

Devices & Diagnostics

Minnesota device maker BridgePoint Medical raises $1m

BridgePoint Medical Inc. has raised $1 million from the sale of debt and stock warrants, according to documents filed with the Securities and Exchange Commission. The company, based in Plymouth, Minnesota, is developing balloon catheter system to treat chronic coronary and peripheral total occlusions, a condition in which clots frequently clog blood vessels. Last year, […]

Devices & Diagnostics

Boston Scientific cuts lost sales figures

Expanded earnings filings with the Securities and Exchange Commission show Boston Scientific Corp. trimming estimates of lost sales by $200 million. Officials at Boston Scientific Corp. (NYSE:BSX) revealed that a snafu with the U.S. Food & Drug Administration, which led to a month-long suspension of ICD sales last spring will cost the company $300 million […]

Devices & Diagnostics

Epocrates to try $75 million IPO again

Epocrates, a developer of mobile drug reference tools, registers for a $75 million initial public offering — again. Epocrates Inc. plans to go public — again. The company last week filed for an initial public offering that could bring in as much as $75 million, according to a Securities & Exchange Commission filing. Epocrates makes […]

Devices & Diagnostics

DOJ looks into Oracle buyout of Phase Forward

The U.S. Dept. of Justice is investigating Oracle Corp.’s proposed $685 million buyout of Phase Forward Inc. The U.S. Dept. of Justice is investigating Oracle Corp.’s (NSDQ:ORCL) $685 million bid to acquire Phase Forward Inc. (NSDQ: PFWD), according to a filing with the Securities and Exchange Commission. The Waltham, Mass.-based clinical trial data management provider […]